We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

News   Aug 22, 2017 | Original story from UNC Lineberger

 
Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

Credit: Jonathan Serody, MD, UNC Lineberger member and the Elizabeth Thomas Professor in the UNC School of Medicine

 
 
 

RELATED ARTICLES

Making AI Less Biased

News

With machine learning systems now being used to determine everything from stock prices to medical diagnoses, it's never been more important to look at how they arrive at decisions. A new approach out of MIT demonstrates that the main culprit is not just the algorithms themselves, but how the data itself is collected.

READ MORE

High-Tech Scans Should be Used More in Prostate Cancer

News

Modern, sophisticated scans should be used in hospitals to pick out men whose prostate cancers have only spread to a limited number of sites, so they can be offered the chance of cure, a new assessment concludes.

READ MORE

Inflammation-blocking Inhibitor Could Treat Sepsis Too

News

A new inhibitor which decreases lung inflammation could hold the key to treating Acute Respiratory Distress Syndrome and sepsis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE